Clinicians' attitude towards changes in Australian National Cervical Screening Program
- PMID: 26651602
- DOI: 10.1016/j.jcv.2015.11.018
Clinicians' attitude towards changes in Australian National Cervical Screening Program
Abstract
Background: Australian guidelines for cervical cancer screening are being revised under the "renewal program". Physicians' willingness to accept these changes will play a pivotal role in its success.
Objective: To understand the willingness and acceptance of, as well as barriers and facilitators for Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) affiliates to screening using human papillomavirus (HPV) testing, starting at 25 years of age, every 5 years.
Study design: An electronic survey of RANZCOG affiliates was undertaken April-June 2014, while renew was announced April 28th 2014. Responses used a 7 point Likert scale, which was dichotomized as ≤4, indicating 'unwilling' and >4, indicating 'willing' to adopt revised practices.
Results: Response rate was 22% (n=956): 60% were obstetricians and gynaecologists (OG); 27% general practitioner diplomates; 13% OG trainees. Overall, 60% (n=526/874) were willing to revise their screening practice. This correlated with awareness of new guidelines (p=<0.001). Fifty percent (n=438/869) of respondents were concerned about delaying to 25 years, and 48% (n=421/869) concerned cervical cancers would be missed. Reasons respondents gave for wishing to continue screening from 18 years contrary to guidelines included: women not being vaccinated (65.6%), immunosuppressed women (92.2%) and women who had been victims of childhood sexual assault (73.9%).
Conclusions: The majority of RANZCOG affiliates were willing to change screening practice however, a number of barriers to delaying onset of screening age to age 25 years were reported. Effective change management strategies will need to be implemented to address the concerns raised to ensure best practice for cervical screening.
Keywords: Cervical screening; Change management; Gynecologist; HPV testing; Human papillomavirus; Obstetrician; RANZCOG; Renew guidelines.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.J Clin Virol. 2016 Mar;76 Suppl 1:S74-S80. doi: 10.1016/j.jcv.2015.10.026. Epub 2015 Nov 4. J Clin Virol. 2016. PMID: 26589584
-
Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.J Clin Virol. 2016 Mar;76 Suppl 1(Suppl 1):S62-S68. doi: 10.1016/j.jcv.2015.11.020. Epub 2015 Nov 18. J Clin Virol. 2016. PMID: 26631958 Free PMC article. Review.
-
Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.Niger J Clin Pract. 2019 Sep;22(9):1286-1291. doi: 10.4103/njcp.njcp_452_18. Niger J Clin Pract. 2019. PMID: 31489868
-
Knowledge of Cervical Cancer and Human Papillomavirus among Japanese Women.Asian Pac J Cancer Prev. 2020 Dec 1;21(12):3527-3532. doi: 10.31557/APJCP.2020.21.12.3527. Asian Pac J Cancer Prev. 2020. PMID: 33369448 Free PMC article.
-
Implementation of HPV testing in Latin America.J Clin Virol. 2016 Mar;76 Suppl 1:S69-S73. doi: 10.1016/j.jcv.2015.11.035. Epub 2015 Nov 28. J Clin Virol. 2016. PMID: 26699418 Review.
Cited by
-
The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality.J Pathol Clin Res. 2018 Oct;4(4):207-212. doi: 10.1002/cjp2.110. Epub 2018 Sep 11. J Pathol Clin Res. 2018. PMID: 30058126 Free PMC article.
-
Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer.Pathogens. 2023 Mar 13;12(3):451. doi: 10.3390/pathogens12030451. Pathogens. 2023. PMID: 36986373 Free PMC article.
-
A Thematic Analysis of Attitudes Toward Changes to Cervical Screening in Australia.JMIR Cancer. 2019 Apr 11;5(1):e12307. doi: 10.2196/12307. JMIR Cancer. 2019. PMID: 30973340 Free PMC article.
-
Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.J Med Virol. 2018 Jan;90(1):165-171. doi: 10.1002/jmv.24902. Epub 2017 Oct 17. J Med Virol. 2018. PMID: 28710863 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous